Thermo Fisher Scientific's $13.6 Billion Acquisition of Life Technologies Boosts Flagging M&A Numbers May 01, 2013 | Press Release
Burrill Securities Launches Institutional Breakthrough Series April 29, 2013 | Press Release
Big Biotech Outpaces Big Pharma, Burrill & Company says April 16, 2013 | Press ReleaseSee all News
Dr. Waddington serves as Entrepreneur-in-Residence where he is involved in building startup companies across the spectrum of the life sciences. He serves as the President and CEO of Abunda Corporation, a Burrill incubated start-up company that exploits current capabilities in biosynthesis, synthetic biology and nutritional science.
Previously, he spent more than a decade as a venture capitalist. He was a Managing Partner at PolyTechnos Venture-Partners based in
He holds a Ph.D. in physics and an MBA from Harvard Business School (HBS). He is a former board member of the German HBS Alumni Association and currently serves as an International Alumni Ambassador for